Science 37
OverviewSuggest Edit
Science 37 is a mobile technology and clinical trials organization. The company is focused on the development of networked patient-centric models for clinical research to rapidly accelerate biomedical discovery. Science 37 leverages partnerships with national mobile nursing companies, pharmacy chains, patient advocacy groups, virtual e-consenting, mobile devices, and other technology companies to maximize efficiency. Then, using design-thinking principles and rapid prototyping Science 37 puts patients first and brings clinical trials right to their homes.
| Type | Private | |
| Founded | 2014 | |
| HQ | Los Angeles, CA, US | Map |
| Website | science37.com | |
| Employee Ratings | More | |
| Overall Culture | C | More |
Latest Updates
| Employees (est.) (Sept 2021) | 410 | (+6%) |
| Cybersecurity rating | C | More |
Key People/Management at Science 37
David Coman
Chief Executive Officer
Chris Ceppi
Chief Product Officer
Jonathan Cotliar
Chief Medical Officer
Darcy Forman
Chief Delivery Officer
Steve Geffon
Chief Commercial Officer
Mike Zaranek
Chief Financial Officer
Science 37 Office Locations
Science 37 has offices in Los Angeles and Culver City
Los Angeles, CA, US (HQ)
12121 Bluff Creek Dr #100, Playa Vista
Culver City, CA, US
600 Corporate Pointe #320
Science 37 Financials and Metrics
Summary Metrics
Founding Date | 2014 |
Science 37 total Funding | $106.5 m |
Science 37 latest funding size | $40 m |
Time since last funding | a year ago |
Science 37 investors | Glynn Capital Management, Lux Capital, Novartis, Redmile Group, Amgen, Amgen Ventures, Sanofi-Genzyme BioVentures, dRx Capital, GV, Mubadala Ventures, Sanofi Ventures, PPD, LifeSci Ventures |
Science 37's latest funding round in August 2020 was reported to be $40 m. In total, Science 37 has raised $106.5 m
Science 37 Cybersecurity Score
Science 37 Online and Social Media Presence
371 Twitter followers
Science 37 has 371 Twitter Followers. The number of followers has decreased 0.3% month over month and decreased 0.6% quarter over quarter
Science 37's Trends
Science 37 Company Culture
Overall Culture
C
70/100
CEO Rating
C
70/100
Compensation
B
82/100
Science 37 News and Updates
August 20, 2020
Science 37, a virtual trials startup once eyed by Alphabet's Verily, just raised $40 million to push the drug industry decades into the future
Science 37 just raised $40 million for its online approach to drug research.
Coronavirus sent new business its way, as outbreaks shut down hospitals that normally run trials.
Now, the startup is fielding new business from top drugmakers and plans to expand around the world.
It also caught the att…
Science 37 Blogs
January 21, 2021
Science 37® Launches “Science 37 Certified” to Enable CROs to Effectively Execute Decentralized Clinical Trials
Science 37’s flexible Science 37 Certified program provides contract research organizations (CROs) with direct access to its Operating System to enable decentralized trial solutions. LOS ANGELES, January 21, 2021 — Science 37, the industry leader in decentralized clinical trials, today announced a…
September 16, 2020
Science 37® Supports DCRI’s First Direct-to-Family Study for Pediatric Lupus
Science 37 is excited to be part of the first-of-its-kind direct-to-family study with the Duke Clinical Research Institute (DCRI) for decentralized research in pediatric lupus. The iPERSONAL (Individual Patient Exposure and Response in Pediatric Lupus) study will help determine the most effective do…
September 10, 2020
Science 37® Integrates Electronic Health Records into Its Decentralized Clinical Trial Technology Platform
Patients using Science 37’s technology platform can now connect their health record directly, in real time—eliminating paper documentation and streamlining information sharing. LOS ANGELES, September 10, 2020 — Science 37, the industry leader in decentralized clinical trials, today launched an ele…
August 12, 2020
Science 37® Named to 2020 CB Insights Digital Health 150—List of Most Innovative Digital Health Start-Ups
Science 37, the industry leader in decentralized clinical trials, has been named to the Digital Health 150, CB Insights’ annual ranking of the most promising digital health companies in the world.
The post Science 37® Named to 2020 CB Insights Digital Health 150—List of Most Innovative Digital Heal…
July 29, 2020
Science 37® and Advarra Detail Methods for Research Continuity
A new whitepaper from Science 37 and Advarra explores how research is continuing in the COVID-19 era. Although many nations appear to have turned the tide in the current global pandemic, the effects of COVID-19 will continue to reverberate for months and years to come. As we continue in this era, …
July 27, 2020
Science 37® Furthers Global Expansion and Decentralized Trial Leadership
Science 37 adds to its industry-leading virtual trial capabilities in Europe, South America, and Asia-Pacific. LOS ANGELES, July 28, 2020 — Science 37, the industry leader in decentralized clinical trials, today announced a series of global investments, including an expanded European, Latin Ameri…
Science 37 Frequently Asked Questions
When was Science 37 founded?
Science 37 was founded in 2014.
Who are Science 37 key executives?
Science 37's key executives are David Coman, Chris Ceppi and Jonathan Cotliar.
How many employees does Science 37 have?
Science 37 has 410 employees.
Who are Science 37 competitors?
Competitors of Science 37 include Elligo Health Research, Open as App and Driftscape.
Where is Science 37 headquarters?
Science 37 headquarters is located at 12121 Bluff Creek Dr #100, Playa Vista, Los Angeles.
Where are Science 37 offices?
Science 37 has offices in Los Angeles and Culver City.
How many offices does Science 37 have?
Science 37 has 2 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies